T
ABBV icon

TRUADVICE’s AbbVie ABBV Stock Holding History

TRUADVICE’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$256K Buy
1,846
+430
+30% +$63.1K 0.1% 193
2023
Q2 		$214K Buy
+1,416
New +$208K 0.08% 242
2021
Q3 		– Sell
-6,129
Closed -$723K – 118
2021
Q2 		$723K Buy
6,129
+456
+8% +$51.4K 0.16% 126
2021
Q1 		$629K Sell
5,673
-4,516
-44% -$483K 0.19% 107
2020
Q4 		$1.05M Buy
10,189
+1,269
+14% +$122K 0.32% 77
2020
Q3 		$777K Buy
+8,920
New +$840K 0.32% 76

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRUADVICE's ABBV Position: Q3 2023 in Review

TRUADVICE increased its AbbVie (ABBV) stake by 30% in Q3 2023, buying an estimated $63.1K and bringing the position to 1,846 shares worth $256K. The position accounts for 0.1% of the portfolio, ranked #193.

TRUADVICE first reported a position in ABBV in Q3 2020 and has held it in 6 quarters since. The position peaked at $1.05M in Q4 2020. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • TRUADVICE held 1,846 shares of AbbVie worth $256K as of Q3 2023.
  • TRUADVICE bought 430 AbbVie shares in Q3 2023, an estimated $63.1K.
  • AbbVie made up 0.1% of TRUADVICE's portfolio in Q3 2023, its #193 holding.
  • TRUADVICE first reported a position in AbbVie in Q3 2020 and has held it in 6 quarters since.
  • TRUADVICE's AbbVie position peaked at $1.05M in Q4 2020.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on TRUADVICE's 13F filing for Q3 2023, filed 13 Nov 2023.